$0.659
+0.017 (+2.62%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de LAB por análisis de gráficos similares
Alphio's LAB stock price prediction model matches the current Standard BioTools Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.66 (+0.40%). The 1-week path is $0.68 (+3.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Standard BioTools Inc?
Standard BioTools Inc (LAB) is currently trading at $0.6419, which is significantly lower than its 200-day simple moving average of $1.075, indicating a bearish trend. The stock has a low RSI of 24.478, suggesting it is oversold, but this could also indicate continued weakness. Additionally, the forward P/E ratio is 0, reflecting uncertainty in future earnings. While the recent merger with Treeline Biosciences could strengthen its financial position, the company has reported a net income loss of $26,758,000 in Q2 2026, which raises concerns about its profitability and operational efficiency. Given these factors, it may be prudent to hold off on buying until there is clearer evidence of recovery or improvement in financial metrics.
LAB cerró en $0.66 el Monday, tras subir +2.62%
Standard BioTools Inc (LAB) last closed at $0.6587, gaining +2.62%. These facts feed the 1-day and 1-week LAB price prediction above.
Factores de la previsión
Los factores de la previsión de Standard BioTools Inc (LAB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de LAB, ordenadas por similitud.
Análisis de estacionalidad de LAB
Historically the probability of a positive September return for LAB is 0.00%. January offers the highest probability of a positive month at 63.93%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de LAB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $1.45 | $1.46 | $1.75 | +122.06% |
| Oct 2026 | $0.97 | $1.27 | $1.38 | +92.61% |
| Nov 2026 | $1.46 | $1.72 | $2.08 | +160.50% |
| Dec 2026 | $1.02 | $1.46 | $1.51 | +121.38% |
En 2026, se proyecta que Standard BioTools Inc (LAB) oscile entre $0.97 y $2.08.
Previsión mensual de Standard BioTools Inc para 2026
En Sep de 2026, se proyecta que Standard BioTools Inc promedie $1.46, con un mínimo de $1.45 y un máximo de $1.75.
En Oct de 2026, se proyecta que Standard BioTools Inc promedie $1.27, con un mínimo de $0.97 y un máximo de $1.38.
En Nov de 2026, se proyecta que Standard BioTools Inc promedie $1.72, con un mínimo de $1.46 y un máximo de $2.08.
En Dec de 2026, se proyecta que Standard BioTools Inc promedie $1.46, con un mínimo de $1.02 y un máximo de $1.51.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.